Home | GSKSkip to contentSkip to searchBehind the Science magazineCompany Company Purpose, strategy and cultureGSK at a glanceHistory and heritageBoard of Directors and Executive CommitteeBoard informationGovernance Governance CommitteesShareholdersSarbanes-Oxley Act 2002CompliancePolicy positionsCodes, standards and reportsInnovation Innovation Our leading scientists Our leading scientists Dr Tony WoodDr Sabine LuikDr Hesham Ahmed AbdullahDr Kaivan KhavandiDr Christopher AustinCharlotte AllertonDr Sanjay GurunathanResearch and development approachPipelineTherapeutic areas Therapeutic areas Respiratory, immunology and inflammationOncologyHIVInfectious diseasesTech Tech Post-quantum cryptographyClinical trials at GSK Clinical trials at GSK Provision of unapproved medicines for unmet medical needsData transparencyRepresentative clinical studiesPartnering with GSK Partnering with GSK Supported studiesR&D locations R&D locations Flagship R&D centre in Cambridge, UKProducts Products Product areasProducts A-ZResponsibility Responsibility AccessGlobal health and health security Global health and health security Global healthHealth securityUsing our science for global healthImproving access to healthcareAfrica Open LabEnvironment Environment ClimateFreshwaterLandOceansMaterials and wasteHealth system sustainabilityInclusionEthical standards Ethical standards Working with third partiesPublic policy and patient advocacyHuman rightsUse of animalsEngaging with healthcare professionalsProduct governanceGrants and donationsCharitable investments Responsibility reports Responsibility reports Reports archiveInvestors Investors Why invest in GSK?Quarterly resultsFinancial reports Financial reports Annual Report 2025Corporate reports archiveResponsible businessSpeeches and presentationsScience publicationsEvents calendarDividend and share price Dividend and share price GSK share priceShare price calculators (GBp/USD)Dividend calculators (GBp/USD)Dividend calendarAnalyst consensusStock exchange announcements Stock exchange announcements London (RNS)London (RNS) inside informationNew York (SEC)Sign up for announcementsShareholder information Shareholder information Manage your sharesAnnual General MeetingGeneral MeetingAnnual Governance MeetingCorporate sponsored nominee serviceOur ADR programmeAsset reunification - Georgeson Share scam alertPrivacy notice for ordinary shareholdersFAQsCorporate actions Corporate actions Consumer Healthcare DemergerConsumer Healthcare Joint VentureAgreement to acquire TESARODebt investorsInvestor contactsMedia Media Press releasesMedia contactsMedia libraryMedia statementsOur social mediaPodcastsRSS feedsCareers Careers Search jobsFeatured careers Featured careers A career in dataLife at GSKOutstanding people Outstanding people Great place to workMeet our veteransWorking togetherMy GSK storyInnovating togetherExperienced professionals Experienced professionals Business operationsEngineering at GSK Global supply chainSales and marketingResearch and development Research and development Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)Genomic sciencesTechnologyEarly careers Early careers Application processApprentice programmesInternships and placementsGraduate programme Graduate programme Business operationsEngineeringManufacturing & supplyCommercial Research & developmentManufacturing sciences & technologyPost graduate opportunitiesFrequently asked questionsVeteransOur global and regional hubsHow we hire How we hire Fraudulent internet recruitment activitiesFrequently asked questionsDark modeSwitch to dark mode to head towards a more sustainable world together. More infoHealthcare professionals Healthcare professionalsContact us Contact usGSK HomepageChange locationSearchMenu Global Change locationDark modeSwitch to dark mode to head towards a more sustainable world together. More infoHealthcare professionals Healthcare professionalsContact us Contact us SearchGSK HomepageBehind the Science magazineCompanyInnovationProductsResponsibilityInvestorsMediaCareersInvestorsQ2 Results & Accelerate Growth eventQuarterly resultsWatch webcast replayClose videoInnovationNew flagship R&D centre in Cambridge, UKWe will be establishing a new flagship R&D centre in Cambridge Biomedical Campus, one of the world's leading life sciences ecosystemsRead the press releaseClose videoWho we areAs a focused biopharma company, we discover, develop and deliver medicines and vaccines to create value for patients and shareholders. We aim to positively impact the health of 2.5 billion people by the end of the decade.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.​Purpose, strategy and cultureWhy invest in GSK?Respiratory, immunology and inflammation7mdeaths each year due to lung diseasesGo to respiratory, immunology and inflammationOncology~10mpeople die from cancer each yearGo to oncologyHIV40mpeople living with HIV globallyGo to HIVInfectious diseases1 in 7deaths globally caused by infectious diseaseGo to infectious diseasespreviousnextBehind the ScienceExploring how today's discoveries are shaping tomorrow's health'I had dreams': How HIV care has evolved across a generation'Long-acting options are the future to prevent transmission of HIV'‘It’s always there’: Learning to live with chronic hepatitis B‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine developmentAntibody-drug conjugates: Advancing the search for more targeted cancer treatmentMapping disease at the cellular level: A single-cell revolution in drug discoveryWhy adults aged 50 years and older with certain long-term health conditions need to make their move to help protect against this common respiratory virus'The ever-present threat of contracting a UTI means my daily routine is ruled by measures to reduce my risk''We’re innovating to help keep COPD patients out of hospital and exacerbation-free''Prevention is the best medicine to stop disease before it starts'previousnextRead our magazineINVESTORSWe announced our second quarter 2026 results on Tuesday 28 JulyView latest resultsContinue to Company Gsk LogoThis is our global website, intended for visitors seeking information on GSK’s worldwide business.  Our market sites can be reached by visiting our location selector.     © 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act Statement 2025 (PDF - 187.7KB)GSK websitesLocations selectorSocial media directoryGSKPro for healthcare professionalsGSK study registerSupplier websiteViiV HealthcareQuick linksBehind the Science magazineCompanyInnovationProductsResponsibilityInvestorsMediaCareersGet in touchContact usPartnershipsReport a possible side effectGSK Speak upFollow us on:AccessibilityDigital sustainabilityTerms of useCookie policyPrivacy noticeSitemap